A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection

Cancer Letters

Volumn 229, Issue 1, 2005, Pages 77-83

  Zhu, Zhong Zheng ^a   Cong, Wen Ming ^a   Liu, Shu Fang ^b   Xian, Zhi Hong ^a   Wu, Wei Qing ^a   Wu, Meng Chao ^a   Gao, Bin ^c   Hou, Li Fang ^d   Zhu, Guan Shan ^c,e  

^a EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

^b TONGJI UNIVERSITY   (China)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DNA polymorphisms; Hepatitis B virus; Hepatocellular carcinoma; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENOMICS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CODON; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

HEPATITIS B VIRUS;

EID: 24344491812     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.04.014     Document Type: Article

References (40)

1. F.X. Bosch, J. Ribes, and J. Borras Epidemiology of primary liver cancer Semin. Liver Dis. 19 1999 271 285
2. J.H. Kao, and D.S. Chen Recent research progress in hepatocellular carcinoma J. Formos. Med. Assoc. 101 2002 239 248
3. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int. J. Cancer 94 2001 153 156
4. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
5. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat. Genet. 31 2002 339 346
6. M.A. Buendia Genetics of hepatocellular carcinoma Semin. Cancer Biol. 10 2000 185 200
7. M. Anzola, N. Cuevas, M. Lopez-Martinez, A. Saiz, J.J. Burgos, and M. Martinez de Pancorboa P14ARF gene alterations in human hepatocellular carcinoma Eur. J. Gastroenterol. Hepatol. 16 2004 19 26
8. M.W. Yu, S.Y. Yang, I.J. Pan, C.L. Lin, C.J. Liu, and Y.F. Liaw Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma J. Natl Cancer Inst. 95 2003 1485 1488
9. A. Vogel, S. Kneip, A. Barut, U. Ehmer, R.H. Tukey, M.P. Manns, and C.P. Strassburg Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene Gastroenterology 121 2001 1136 1144
10. Y. Wang, N. Kato, Y. Hoshida, H. Yoshida, H. Taniguchi, and T. Goto Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection Hepatology 37 2003 65 71
11. H.D. Shin, B.L. Park, L.H. Kim, J.H. Jung, J.Y. Kim, and J.H. Yoon Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma Hum. Mol. Genet. 12 2003 901 906
12. M.W. Yu, Y.H. Chiu, S.Y. Yang, R.M. Santella, H.D. Chern, Y.F. Liaw, and C.J. Chen Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers Br. J. Cancer 80 1999 598 603
13. M.W. Yu, C.I. Pai, S.Y. Yang, T.J. Hsiao, H.C. Chang, and S.M. Lin Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk Gut 47 2000 703 709
14. P. Dumont, J.I. Leu, A.C. Della Pietra 3rd, D.L. George, and M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat. Genet. 33 2003 357 365
15. C.E. Irarrazabal, C. Rojas, R. Aracena, C. Marquez, and L. Gil Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53 Toxicol. Lett. 144 2003 69 76
16. J.M. Lee, Y.C. Lee, S.Y. Yang, W.L. Shi, C.J. Lee, and S.P. Luh Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus Int. J. Cancer 89 2000 458 464
17. T. Hiyama, S. Tanaka, Y. Kitadai, M. Ito, M. Sumii, and M. Yoshihara p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis Int. J. Cancer 100 2002 304 308
18. A. Sjalander, R. Birgander, G. Hallmans, S. Cajander, P. Lenner, and L. Athlin p53 polymorphisms and haplotypes in breast cancer Carcinogenesis 17 1996 1313 1316
19. M.H. Tsai, C.D. Lin, Y.Y. Hsieh, F.C. Chang, F.J. Tsai, W.C. Chen, and C.H. Tsai Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma Laryngoscope 112 2002 116 119
20. Y. Kuroda, H. Tsukino, H. Nakao, H. Imai, and T. Katoh p53 Codon 72 polymorphism and urothelial cancer risk Cancer Lett. 189 2003 77 83
21. K. Suzuki, H. Matsui, N. Ohtake, S. Nakata, T. Takei, and H. Nakazato A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese J. Biomed. Sci. 10 2003 430 435
22. Y.C. Chen, L. Xu, Y.L. Guo, H.J. Su, Y.M. Hsueh, and T.J. Smith Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan J. Environ. Sci. Health Part A Tox. Hazard Subst. Environ. Eng. 38 2003 201 211
23. L.M. Pierce, L. Sivaraman, W. Chang, A. Lum, T. Donlon, and A. Seifried Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population Cancer Epidemiol. Biomarkers Prev. 9 2000 1199 1204
24. M.T. Wu, M.C. Chen, and D.C. Wu Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan Cancer Lett. 205 2004 61 68
25. E.N. Papadakis, D.N. Dokianakis, and D.A. Spandidos p53 codon 72 polymorphism as a risk factor in the development of breast cancer Mol. Cell Biol. Res. Commun. 3 2000 389 392
26. G.A. Toruner, A. Ucar, M. Tez, M. Cetinkaya, H. Ozen, and T. Ozcelik P53 codon 72 polymorphism in bladder cancer - no evidence of association with increased risk or invasiveness Urol. Res. 29 2001 393 395
27. S.P. Huang, W.J. Wu, W.S. Chang, M.T. Wu, Y.Y. Chen, and Y.J. Chen p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer Cancer Epidemiol. Biomarkers Prev. 13 2004 2217 2224
28. D.P. O'Connor, E.W. Kay, M. Leader, G.J. Atkins, G.M. Murphy, and M.J. Mabruk p53 codon 72 polymorphism and human papillomavirus associated skin cancer J. Clin. Pathol. 54 2001 539 542
29. M.W. Yu, S.Y. Yang, Y.H. Chiu, Y.C. Chiang, Y.F. Liaw, and C.J. Chen A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers Hepatology 29 1999 697 702
30. M. Leveri, C. Gritti, L. Rossi, C. Zavaglia, E. Civardi, and M.U. Mondelli Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients Cancer Lett. 208 2004 75 79
31. M. Anzola, N. Cuevas, M. Lopez-Martinez, A. Saiz, J.J. Burgos, and M.M. de Pancorbo Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma Cancer Lett. 193 2003 199 205
32. S. Ara, P.S. Lee, M.F. Hansen, and H. Saya Codon 72 polymorphism of the TP53 gene Nucleic Acids Res. 18 1990 4961
33. R.P. Beasley, L.Y. Hwang, C.C. Lin, and C.S. Chien Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan Lancet 2 1981 1129 1133
34. H.I. Yang, S.N. Lu, Y.F. Liaw, S.L. You, C.A. Sun, and L.Y. Wang Hepatitis B e antigen and the risk of hepatocellular carcinoma N. Engl. J. Med. 347 2002 168 174
35. B.L. Slagle, Y.Z. Zhou, and J.S. Butel Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas Cancer Res. 51 1991 49 54
36. L. Jia, X.W. Wang, and C.C. Harris Hepatitis B virus X protein inhibits nucleotide excision repair Int. J. Cancer 80 1999 875 879
37. S.G. Lee, and H.M. Rho Transcriptional repression of the human p53 gene by hepatitis B viral X protein Oncogene 19 2000 468 471
38. H. Ueda, S.J. Ullrich, J.D. Gangemi, C.A. Kappel, L. Ngo, M.A. Feitelson, and G. Jay Functional inactivation but not structural mutation of p53 causes liver cancer Nat. Genet. 9 1995 41 47
39. X.W. Wang, K. Forrester, H. Yeh, M.A. Feitelson, J.R. Gu, and C.C. Harris Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 Proc. Natl Acad. Sci. USA 91 1994 2230 2234
40. A. Storey, M. Thomas, A. Kalita, C. Harwood, D. Gardiol, and F. Mantovani Role of a p53 polymorphism in the development of human papillomavirus- associated cancer Nature 393 1998 229 234